[TEVA] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
15-Nov-2016
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -379.60%
YoY- -294.60%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 4,468,000 4,559,000 5,459,000 6,492,000 4,881,000 5,168,000 5,430,000 -3.19%
PBT -38,000 -3,387,000 -13,208,000 -914,000 861,000 872,000 501,000 -
Tax -119,000 -139,000 -1,471,000 57,000 249,000 186,000 114,000 -
NP 109,000 -2,886,000 -11,535,000 -973,000 500,000 687,000 380,000 -18.78%
Tax Rate - - - - -28.92% -21.33% -22.75% -
Total Cost 4,359,000 7,445,000 16,994,000 7,465,000 4,381,000 4,481,000 5,050,000 -2.42%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 2.44 -63.30 -211.30 -14.99 10.24 13.29 7.00 -16.10%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS 0.10 -2.80 -11.34 -0.96 0.56 0.80 0.45 -22.16%
EPS Diluted 0.10 -2.80 -11.34 -0.96 0.55 0.80 0.45 -22.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.